Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single and multiple dose pharmacokinetic study of maraviroc in subjects with varying degrees of renal impairment and normal renal function
2008-000355-94Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Pfizer. Primary endpoints: AUCtlast/tau, Cmax and 1 more. Started May 2008; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-000355-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000355-94.